Prot #13084: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of BAY 41-6551 as Adjunctive Therapy in Intubated and Mechanically-Ventilated Patients with Gram-Negative Pneumonia

Project: Research project

Project Details

StatusFinished
Effective start/end date8/12/13 → 9/28/17

Funding

  • Covance Inc. (Prot #13084)
  • Bayer HealthCare Pharmaceuticals, Inc. (Prot #13084)